Log in
NYSE:TEVA

Teva Pharmaceutical Industries Price Target, Predictions & Analyst Ratings

$8.80
+0.08 (+0.92 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.70
Now: $8.80
$8.88
50-Day Range
$8.57
MA: $9.73
$11.92
52-Week Range
$6.25
Now: $8.80
$13.76
Volume4.40 million shs
Average Volume14.51 million shs
Market Capitalization$9.61 billion
P/E Ratio3.81
Dividend YieldN/A
Beta1.5

Analyst Ratings

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Teva Pharmaceutical Industries in the last 12 months. Their average twelve-month price target is $12.36, predicting that the stock has a possible upside of 40.42%. The high price target for TEVA is $16.00 and the low price target for TEVA is $8.00. There are currently 3 sell ratings, 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
TEVA Consensus Rating: HoldHoldHoldHold
TEVA Consensus Rating Score: 2.172.112.092.08
TEVA Analyst Ratings: 3 Sell Rating(s)
9 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
12 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
14 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
TEVA Consensus Price Target: $12.36$12.36$11.50$11.40
TEVA Price Target Upside: 40.42% upside27.79% upside8.22% downside37.68% upside

Teva Pharmaceutical Industries (NYSE:TEVA) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Teva Pharmaceutical Industries (NYSE:TEVA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/14/2020Raymond JamesReiterated RatingBuyLow
8/26/2020Bank of AmericaReiterated RatingSell$8.00Low
8/6/2020SVB LeerinkBoost Price TargetMarket Perform$13.00 ➝ $14.00Medium
8/6/2020BarclaysUpgradeUnderweight ➝ Equal Weight$10.00 ➝ $13.00Medium
7/27/2020Goldman Sachs GroupInitiated CoverageNeutral$12.00Low
6/1/2020SunTrust BanksUpgradeHold ➝ Buy$11.00 ➝ $16.00High
5/11/2020UBS GroupBoost Price TargetBuy$12.00 ➝ $15.00Medium
5/8/2020Cantor FitzgeraldReiterated RatingNeutralLow
4/24/2020CitigroupInitiated CoverageNeutralLow
4/15/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00Low
4/2/2020Morgan StanleyLower Price TargetUnderweight$13.00 ➝ $8.00Medium
3/5/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$10.00 ➝ $12.00Low
2/24/2020Edward JonesDowngradeHold ➝ SellHigh
2/18/2020ArgusBoost Price TargetBuy$10.00 ➝ $15.00Low
2/13/2020OppenheimerBoost Price TargetOutperform$12.00 ➝ $16.00High
2/12/2020CfraBoost Price TargetHold$11.00 ➝ $13.00Low
11/12/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$8.00Medium
10/16/2019GabelliUpgradeHold ➝ BuyHigh
9/12/2019GuggenheimInitiated CoverageNeutralLow
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$11.00 ➝ $9.00N/A
8/8/2019Royal Bank of CanadaReiterated RatingHold$10.00High
8/7/2019CowenSet Price TargetHold$9.00Low
7/19/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer Perform$9.00Low
7/10/2019Credit Suisse GroupReiterated RatingNeutralLow
6/18/2019Sanford C. BernsteinLower Price TargetMarket Perform$17.00 ➝ $11.00Medium
6/17/2019MizuhoSet Price TargetHold$11.00Medium
6/3/2019CIBCUpgradeMarket Perform ➝ Outperform$12.00Medium
5/2/2019Maxim GroupReiterated RatingHoldLow
2/5/2019HSBCSet Price TargetSell$12.00High
1/23/2019Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$15.00 ➝ $16.00Low
9/17/2018BTIG ResearchUpgradeSell ➝ NeutralHigh
8/3/2018Jefferies Financial GroupReiterated RatingHold$21.00Medium
2/9/2018Deutsche BankLower Price TargetHold ➝ Hold$20.00 ➝ $18.00Medium
1/25/2018Susquehanna BancsharesReiterated RatingPositive ➝ Positive$22.00 ➝ $24.00Medium
10/25/2017Evercore ISISet Price TargetBuy$38.00N/A
(Data available from 9/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.